Mesenchymal stem cells-derived exosomes for drug delivery

Area of Science:

• Biotechnology
• Nanomedicine
• Cell Biology

Background:

• Exosomes are lipid bilayer vesicles crucial for intercellular communication.
• Targeted drug delivery offers potential for treating complex diseases like tumors and Alzheimer's disease (AD).
• Mesenchymal stem cell-derived exosomes (MSC-EXOs) are investigated as natural drug delivery vehicles.

Purpose of the Study:

• To review the current research on MSC-EXOs for drug delivery applications.
• To summarize the characteristics, production, purification, and drug loading methods of MSC-EXOs.
• To identify existing challenges and propose future research directions for MSC-EXO-based drug delivery.

Main Methods:

• Literature review of studies on MSC-EXOs in drug delivery.
• Analysis of MSC-EXO properties, including immunological, tumor-homing, and elastic characteristics.
• Examination of various production, purification, and drug loading techniques.

Main Results:

• MSC-EXOs possess favorable properties for drug delivery, such as biocompatibility and targeting capabilities.
• Established methods for MSC-EXO production, purification, and drug loading exist, though optimization is needed.
• Existing challenges include scalability, yield, and efficient drug encapsulation.

Conclusions:

• MSC-EXOs represent a promising platform for targeted drug delivery, particularly for tumors and AD.
• Further research is required to overcome current limitations in production and drug loading for clinical translation.
• Optimizing MSC-EXO-based therapies could significantly advance treatment strategies for refractory diseases.